Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1994-09-15
1998-11-03
Adams, Donald E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241841, 424 931, 4241601, 435 721, A61K 3921, A61K 3900, A61K 3942, A01N 6300
Patent
active
058304762
ABSTRACT:
The instant invention provides for isolated gp48 glycoprotein, methods of passive immunization with anti-gp48 antibodies, and methods of active immunization for generating anti-gp48 antibodies.
REFERENCES:
patent: 5286852 (1994-02-01), Osther et al.
Buchegger et al., (1987) Swine Monoclonal Antibodies of High Affinity and Specificity to Carcinoembryonic Antigen, JNCI 79(2):337-342.
Osther et al., (1992) PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a Phase I trial of hyperimmune porcine immunoglobulin to HIV-1, AIDS 6:1457-1464.
Kwang et al. Vetrinary Microbiology 32(3-4) pp.281-92. Oct. 1992.
Hung Chung-Ho
Osther Kurt B.
Adams Donald E.
Nelson Brett L.
Verigen Inc.
LandOfFree
Active induction or passive immunization of anti-Gp48 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Active induction or passive immunization of anti-Gp48 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active induction or passive immunization of anti-Gp48 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686737